Synovial sarcoma (SS) is a rare malignant neoplasm that arises most commonly in joint capsules and articular tendons, but its relationship to the synovium is not always obvious. Synovial sarcoma is a malignant soft tissue tumor representing 5.6% to 10% of all soft tissue sarcomas. They are termed SS because of their histologic resemblance to the synovium, but they rarely involve a synovial structure and are thought to arise from pluripotential mesenchymal cells. The tumor usually occurs in close association with tendon sheaths, bursae, and joint capsules, primarily in the para-articular regions of the extremities, with approximately 9% occurring in the head and neck region. Synovial sarcoma has been reported rarely in the oral cavity. We report a very rare case of Synovial sarcoma of the buccal mucosa in a 24-year-old male patient.
Aplasia of condyle is very rare, when this condition not seen as a part of a syndrome. We report a case of condylar aplasia on the right side and hypoplasia on the left side in a 21-year-old female. The patient reported to the department with a chief complaint of underdeveloped lower jaw. Clinical examination, conventional radiographs, and 3D CBCT images revealed complete absence of condyle on the right side and hypoplasia on the left side.
Context:Dental evidence is a valuable tool in identifying individuals, especially when disasters befall. Reference points in faciomaxillary region such as interpupillary distance, intercanthal distance, interalar distance and bizygomatic width can significantly contribute toward reconstruction of two-dimensional (2D) facial profiles. This study was researched upon to determine the relationship between the maxillary intercanine width and the different reference points of the face.Aim:The aim of the following study is to ascertain whether maxillary intercanine width can be used to detect interpupillary distance, intercanthal distance, interalar distance and bizygomatic distance and to evaluate the role of maxillary intercanine width in the 2D reconstruction of the face.Materials and Methods:The study was carried out by consent and involved 90 subjects-45 males and 45 females who satisfied the inclusion criteria. Subjects were divided into three age groups, i.e. 18-24, 25-28, 29-35. Four parameters were measured– intercanine width, interpupillary distance, intercanthal distance and interalar distance. All the measurements were carried out with a digital Vernier caliper. The bizygomatic width was measured from posterior-anterior view. Two empiricists were assigned for the task. Each test was carried out twice to validate the soundness of the findings and to reduce bias.Statistical Analysis:Analysis of variance and Pearson correlation was established. Regression analysis was performed to predict the study variables by intercanine width.Results:Intercanine width showed a significant relationship with different points. The width varied with age and gender.Conclusion:Inter canine width can be used as a valuable parameter in the reconstruction of face in two dimensional as it shows significant relationship with faciomaxillary reference point such as interpupillary distance, intercanthal distance, interalar distance and bizygomatic width.
Patients with human immunodeficiency virus (HIV) infection have been reported to have parotid swellings of various types such as diffuse infiltrative lymphocytosis syndrome, parotitis, intraparotid lymphadenopathy, benign lymphoepithelial cyst (BLEC), as well as salivary gland neoplasms such as adenoid cystic carcinoma, Kaposi sarcoma and lymphoma. LECs in the parotid gland are uncommon benign entities with increased incidence associated with HIV infection. We are presenting a case of 28-year-old HIV-positive patient with BLECs in the parotid and submandibular glands.
There are many disorders affecting the oral cavity, which can cause difficulty in diagnosis for an oral physician. A criterion is defined as 'a principle or standard by which something may be judged or decided'. Several criteria have been given by different authors or committee, which further aids in diagnosis of certain disease. This article encompasses a collection and analysis of all the criteria of diseases affecting the oral cavity, which will be beneficial for an oral physician in their routine clinics.
Background: Sclerotherapy is defined as the “targeted elimination of small vessels, varicose veins and vascular anomalies by the injection of a sclerosant. This study aimed to analyze the effect of a sclerosing agent 3% Sodium tetradecyl sulfate (STS) on different oral lesions and to evaluate whether sclerotherapy can be a potent alternative to other treatment modalities. Methods: A descriptive study was done in the Department of Oral Medicine and Radiology and the Department of Oral and Maxillofacial Surgery, Nobel Medical College Teaching Hospital, Biratnagar between September 2016 and June 2019. Results: A Total of 46 patients treated by 3%STS were retrospectively identified. After exclusion, 38 patients were selected for the study. Out of 38 patients 9 belonged to vascular malformation group, 15 to pyogenic granuloma group, 2 to lymphangioma group, 8 to mucocele group and 4 to ranula group. 25 patients (65.79%) showed complete response, 4 patients (10.53%) showed good response, 3 patients (7.89%) showed moderate response, 2 patients (5.26%) showed mild response and 4 patients (10.53%) showed no response. Conclusions: Sclerotherapy with sodium tetradecyl sulfate 3% is effective in the treatment of different oral lesions such as vascular malformations, pyogenic granuloma, lymphangioma, and mucocele.
Keywords: lymphangioma; mucocele; pyogenic granuloma; sclerotherapy; sodium tetradecyl sulfate; vascular malformation
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.